Antiblastic treatment of hematological malignancies during pregnancy poses a number of issues related to the curability of the maternal disease, the need of a prompt treatment and the potential toxicity of chemotherapy for the fetus. Here we report the results of a systematic literature search about the management of the most frequent hematological malignancies that may occur during pregnancy, focusing on specific issues related to gestational age at diagnosis, fetal toxicity and efficacy on the maternal side. The standard approach in non-pregnant women is illustrated as reference.
|Number of pages||12|
|Journal||International Journal of Immunopathology and Pharmacology|
|Publication status||Published - Apr 1 2012|
- Hematological malignancies
ASJC Scopus subject areas
- Immunology and Allergy